Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.3150 (8.94%) ($12.9150 - $14.3600) on Wed. Nov. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 47 | Latest Price | $14.3150(8.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.825% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-11%) UUP(-8%) TLT(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $5.64(-60.6%) | 5 Day Moving Average | $13.31(7.55%) | 10 Day Moving Average | $13.75(4.11%) | 20 Day Moving Average | $13.93(2.76%) | To recent high | -9.8% | To recent low | 20.1% | Market Cap | $1.064b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |